Truist Financial’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Truist Financial’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,635	Closed	-$571K	–	2863
2021 Q1	$571K	Sell	2,635 -13,668	-84%	-$2.57M	﹤0.01%	1896
2020 Q4	$1.88M	Sell	16,303 -2,426	-13%	-$272K	﹤0.01%	1192
2020 Q3	$1.82M	Buy	18,729 +3,526	+23%	+$406K	﹤0.01%	1104
2020 Q2	$1.87M	Buy	15,203 +3,501	+30%	+$397K	﹤0.01%	1062
2020 Q1	$1.02M	Sell	11,702 -926	-7%	-$98.1K	﹤0.01%	1247
2019 Q4	$1.32M	Buy	12,628 +10,802	+592%	+$1.21M	﹤0.01%	1323
2019 Q3	$210K	Buy	1,826 +9	+0.5%	+$1.37K	﹤0.01%	746
2019 Q2	$313K	Buy	1,817 +299	+20%	+$51.7K	0.01%	672
2019 Q1	$256K	Buy	+1,518	New	+$226K	﹤0.01%	695

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Truist Financial's GWPH Position: Q2 2021 in Review

Truist Financial sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 2,635 shares — an estimated $571K sold.

Truist Financial first reported a position in GWPH in Q1 2019 and held it in 9 quarters. The position peaked at $1.88M in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Truist Financial reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Truist Financial sold 2,635 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $571K.
Truist Financial first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 9 quarters.
Truist Financial's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.88M in Q4 2020.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Truist Financial's 13F filing for Q2 2021, filed 16 Aug 2021.